Women's nephrology · KIMS Secunderabad
Preeclampsia and Kidney Disease — Understanding the Connection Between Pregnancy Complications and Kidney Health
Preeclampsia is a serious pregnancy complication defined by new-onset hypertension (blood pressure above 140/90 mmHg) after 20 weeks of gestation, accompanied by proteinuria or other evidence of end-organ damage. It affects 3 to 5% of all pregnancies and is one of the leading causes of maternal and perinatal morbidity and mortality worldwide. The kidneys are central to the preeclampsia story — both as targets of the pathological process and as the organ that determines much of the maternal risk. Understanding the kidney involvement in preeclampsia, and the long-term kidney consequences that persist after delivery, is essential for every woman who has had preeclampsia and every nephrologist who manages them.
At KIMS Secunderabad, the women's nephrology programme — led by Dr. Susmitha Chandragiri — specifically addresses kidney disease in pregnancy and the long-term kidney follow-up of women with a history of preeclampsia, HELLP syndrome, or pregnancy-related AKI. This is a clinical service that most nephrology programmes do not offer specifically, and that many women with a history of preeclampsia urgently need but rarely receive.
How preeclampsia damages the kidneys
The pathological hallmark of preeclampsia in the kidney is glomerular endotheliosis — swelling and proliferation of the glomerular endothelial cells, which blocks the glomerular capillary lumen and reduces the filtration surface. This is caused by the systemic endothelial dysfunction that underlies preeclampsia — driven by an imbalance between angiogenic factors (placenta-derived sFlt-1 and sEng) that are elevated in preeclampsia and pro-angiogenic factors (VEGF, PlGF) that are suppressed. VEGF is particularly important for maintaining glomerular endothelial health — its suppression by excess sFlt-1 directly causes glomerular endotheliosis.
The clinical consequences: proteinuria (from impaired glomerular filtration barrier), reduced eGFR (from reduced glomerular filtration surface), sodium and water retention (contributing to hypertension and oedema), and — in severe cases — oliguric AKI. The good news: glomerular endotheliosis is largely reversible after delivery. Proteinuria typically resolves within 6 to 12 weeks postpartum, and eGFR returns toward baseline as the endotheliosis resolves. The bad news: preeclampsia leaves lasting vascular and kidney consequences that emerge years after the pregnancy.
Preeclampsia as a kidney disease — the diagnostic picture
Features that define preeclamptic kidney involvement
The KIMS women's nephrology team uses the criteria below to identify and stratify kidney involvement in preeclampsia and to plan postpartum follow-up:
Blood pressure — New onset above 140/90 after 20 weeks. Severe: above 160/110.
Proteinuria — 300mg or more in 24-hour urine, or PCR above 30 mg/mmol, or dipstick 2+ on two occasions. Nephrotic-range proteinuria can occur in severe disease.
eGFR / creatinine — May be normal or mildly elevated. Serum creatinine above 90 µmol/L in pregnancy is abnormal (normal pregnancy lowers creatinine by 25% due to increased GFR). Rising creatinine indicates significant kidney involvement.
Uric acid — Elevated uric acid (above 350 µmol/L in the third trimester) is an early marker of preeclampsia — hyperuricaemia precedes proteinuria in many cases.
Platelet count — Thrombocytopenia (below 100,000) indicates severe preeclampsia — may be part of HELLP syndrome.
HELLP syndrome — Haemolysis + Elevated Liver enzymes + Low Platelets — a severe variant of preeclampsia with significant maternal risk. CRRT may be required for AKI in HELLP.
Resolution after delivery — Hypertension, proteinuria, and eGFR typically normalise within 6–12 weeks postpartum. Persistence beyond 12 weeks suggests pre-existing or de novo kidney disease.
Acute kidney injury in preeclampsia and pregnancy
Severe preeclampsia and HELLP syndrome can cause oliguric AKI requiring dialysis support. The mechanisms include: severe glomerular endotheliosis reducing filtration, thrombotic microangiopathy (particularly in aHUS triggered by pregnancy — see KIMS HUS page), acute tubular necrosis from haemodynamic instability, and — in catastrophic HELLP — cortical necrosis. At KIMS, CRRT is available 24/7 for pregnancy-related AKI — managing the critically ill obstetric patient with AKI requires simultaneous nephrology and obstetric expertise. In the postpartum period, a woman who delivered with preeclampsia and has not seen her blood pressure and proteinuria normalise by 6 to 8 weeks requires a nephrology review. Persistent hypertension and proteinuria at this stage may represent: pre-existing kidney disease unmasked by pregnancy, de novo kidney disease triggered by the pregnancy, or residual preeclamptic endotheliosis taking longer to resolve. A kidney biopsy may be appropriate if proteinuria remains above 1 gram per day at 12 weeks postpartum.
Long-term kidney consequences of preeclampsia
Preeclampsia was historically considered a condition that resolved completely after delivery. The evidence accumulated over the past two decades tells a different story — women with a history of preeclampsia carry significant lifetime risks for hypertension, cardiovascular disease, and CKD, and warrant long-term nephrology follow-up.
Two to four times higher lifetime risk of hypertension
Hypertension often develops in the 30s and 40s — a decade earlier than in the general female population. Annual blood pressure measurement after a preeclamptic pregnancy is the simplest and most informative element of long-term follow-up.
Two to three times higher lifetime risk of cardiovascular disease
Coronary artery disease, stroke, and heart failure are all elevated after preeclampsia. Preeclampsia is now recognised as a major independent cardiovascular risk factor in women — comparable in magnitude to traditional risk factors and meriting incorporation into long-term cardiovascular risk assessment.
Significantly higher risk of CKD
Women with a history of preeclampsia have approximately twice the risk of developing proteinuria and CKD in later life. The risk is highest in women who had preeclampsia before 34 weeks of gestation (early-onset preeclampsia), severe preeclampsia, or preeclampsia in multiple pregnancies.
Unmasking of pre-existing subclinical kidney disease
Pregnancy is a metabolic stress test for the kidneys. Women with subclinical CKD that was never diagnosed may first present with preeclampsia as the pregnancy unmasks their underlying kidney vulnerability. These women need post-pregnancy kidney evaluation — pregnancy can be the first warning that previously silent kidney disease exists.
Every woman who has had preeclampsia — particularly early-onset preeclampsia (before 34 weeks), severe preeclampsia, or HELLP syndrome — should have annual blood pressure, eGFR, and urine ACR monitoring for the rest of her life. This follow-up is not routinely offered after the obstetric episode ends, but it is the standard of care. At KIMS, the women's nephrology programme provides this long-term post-preeclampsia monitoring.
When to see a nephrologist after preeclampsia
Any one of the following is an indication for nephrology review at the KIMS women's nephrology clinic:
Proteinuria persisting beyond 12 weeks postpartum.
Blood pressure not normalising by 6 weeks postpartum without antihypertensives.
Creatinine above 100 µmol/L at 6 weeks postpartum.
History of preeclampsia in multiple pregnancies.
Family history of kidney disease or hypertension.
Planning another pregnancy after severe preeclampsia or HELLP syndrome — pre-conception nephrology review to optimise kidney health before the next pregnancy.
New proteinuria or rising creatinine detected in any health check within 5 years of a preeclamptic pregnancy.
Book a Women's Nephrology Consultation at KIMS
Frequently Asked Questions — Preeclampsia and Kidney Disease
For most women, the kidney changes of preeclampsia — glomerular endotheliosis, proteinuria, reduced eGFR — are largely reversible after delivery. Proteinuria typically resolves within 6 to 12 weeks postpartum and eGFR returns to baseline. However, preeclampsia does increase the long-term risk of hypertension, cardiovascular disease, and CKD — not from permanent structural kidney damage from the preeclampsia itself, but from the shared underlying vascular vulnerability that made preeclampsia more likely in the first place, combined with the vascular remodelling effects of the preeclamptic episode. Women with early-onset or severe preeclampsia have a significantly higher lifetime kidney risk than women with uncomplicated pregnancies.
Gestational hypertension is new-onset hypertension (above 140/90) after 20 weeks of gestation without proteinuria or other evidence of end-organ damage. Preeclampsia is gestational hypertension plus proteinuria (above 300mg/24 hours), or gestational hypertension with evidence of end-organ damage — thrombocytopenia, elevated liver enzymes, rising creatinine, pulmonary oedema, or new-onset headache or visual disturbance. Preeclampsia carries higher risks for both mother and baby than gestational hypertension alone. Gestational hypertension can progress to preeclampsia — blood pressure monitoring and regular proteinuria testing throughout the pregnancy are essential to detect this transition.
Yes — most women who have had preeclampsia can have subsequent pregnancies, often without recurrence. However, the risk of preeclampsia in a subsequent pregnancy is elevated: approximately 15 to 25% recurrence risk after one episode of preeclampsia, and higher after early-onset or severe preeclampsia. Pre-conception assessment at KIMS covers: blood pressure control optimisation, urine ACR and eGFR to assess baseline kidney function, and any underlying cause of the preeclampsia (pre-existing kidney disease, antiphospholipid syndrome, thrombophilia). Low-dose aspirin (75 to 100mg daily, started at 12 to 16 weeks of gestation) is recommended in all women with a prior history of preeclampsia and significantly reduces the risk of recurrence.
Several antihypertensives are established as safe in pregnancy: methyldopa (the most studied — first choice), nifedipine (calcium channel blocker — widely used), and labetalol (alpha and beta blocker — safe and effective). ACE inhibitors and ARBs are absolutely contraindicated in pregnancy from the second trimester onwards — they cause fetal renal tubular dysplasia, oligohydramnios, and neonatal AKI. Any woman with pre-existing hypertension on ACE inhibitors or ARBs who becomes pregnant must switch to a safe alternative immediately. At KIMS, women's nephrology review before and during pregnancy specifically addresses antihypertensive safety.
HELLP syndrome — Haemolysis, Elevated Liver enzymes, Low Platelets — is a severe variant of preeclampsia or a separate condition with overlapping features. The kidney manifestations of HELLP are more severe than standard preeclampsia: AKI occurs in approximately 7% of HELLP cases (compared to 2% in preeclampsia without HELLP), and dialysis support is required in the most severe cases. The mechanisms of AKI in HELLP include thrombotic microangiopathy, haemoglobin-induced tubular toxicity from intravascular haemolysis, and haemodynamic compromise from severe hypertension. At KIMS, CRRT is available for HELLP-related AKI. Delivery is the definitive treatment for HELLP syndrome — the nephrology team provides kidney support while the obstetric team manages delivery.
Yes — if you have not had kidney function checked since your preeclamptic pregnancy. The increased lifetime risk of hypertension, cardiovascular disease, and CKD that follows preeclampsia is well-established but widely under-acted upon. A simple check — blood pressure measurement, serum creatinine, and urine ACR — takes 15 minutes and identifies early hypertension or proteinuria while both are still treatable. At KIMS, the women's nephrology service provides this post-preeclampsia health check and sets up an appropriate monitoring frequency based on the severity of the original episode.
Yes — women with a history of preeclampsia have approximately twice the risk of developing CKD compared to women with uncomplicated pregnancies, and this risk increases further with the severity and number of preeclamptic episodes. The mechanism is not fully established — it may reflect shared underlying vascular vulnerability (endothelial dysfunction, impaired angiogenesis) that predisposes to both preeclampsia and CKD, combined with the direct vascular effects of the preeclamptic episode itself. Early-onset preeclampsia (before 34 weeks) carries a significantly higher subsequent CKD risk than late-onset preeclampsia, likely because early-onset disease reflects more severe underlying pathology.
KIMS Secunderabad — Dr. Susmitha Chandragiri (women's nephrology subspecialty), dedicated women's nephrology programme covering kidney disease in pregnancy, preeclampsia management, HELLP syndrome with CRRT support, post-pregnancy kidney monitoring, and pre-conception nephrology counselling. NABH and NABL accredited. Call 040-4488-5000.